Volume 59, Issue 6, Pages (June 2011)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Volume 55, Issue 1, Pages 1-8 (January 2009)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
Volume 64, Issue 3, Pages (September 2013)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 187, Issue 4, Pages e515-e516 (April 2012)
Testosterone Therapy in Men With Prostate Cancer
Volume 63, Issue 5, Pages (May 2013)
Global Trends in Testicular Cancer Incidence and Mortality
Volume 58, Issue 1, Pages (July 2010)
Volume 67, Issue 1, Pages (January 2015)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Volume 49, Issue 2, Pages (February 2006)
Volume 61, Issue 5, Pages (May 2012)
Lymphadenectomy in the Surgical Management of Penile Cancer
Volume 51, Issue 3, Pages (March 2007)
Volume 66, Issue 6, Pages (December 2014)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Volume 122, Issue 3, Pages (March 2002)
Prostate Cancer Epidemic in Sight?
Volume 63, Issue 4, Pages (April 2013)
Volume 63, Issue 1, Pages (January 2013)
Volume 61, Issue 2, Pages (February 2012)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Volume 44, Issue 1, Pages (July 2003)
What is New in Bladder Cancer Diagnosis and Management?
Nomograms for Bladder Cancer
Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 63, Issue 5, Pages (May 2013)
Volume 59, Issue 4, Pages (April 2011)
Volume 69, Issue 3, Pages (March 2016)
Volume 64, Issue 3, Pages (September 2013)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
Volume 59, Issue 1, Pages (January 2011)
Volume 53, Issue 2, Pages (February 2008)
Stephen B. Williams, Ashish M
Volume 61, Issue 5, Pages (May 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.
The Economic Costs of Overactive Bladder in Germany
Volume 50, Issue 5, Pages (November 2006)
Volume 50, Issue 3, Pages (September 2006)
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 1, Pages (January 2008)
The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.
Volume 53, Issue 5, Pages (May 2008)
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Economic Burden of Bladder Cancer Across the European Union
Volume 52, Issue 4, Pages (October 2007)
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Volume 53, Issue 6, Pages (June 2008)
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 59, Issue 6, Pages 1026-1031 (June 2011) Select Screening in a Specific High-Risk Population of Patients Suggests a Stage Migration Toward Detection of Non–Muscle-Invasive Bladder Cancer  Alexandre R. Zlotta, Thierry Roumeguere, Cynthia Kuk, Sultan Alkhateeb, Sandrine Rorive, Anne Lemy, Theodorus H. van der Kwast, Neil E. Fleshner, Michael A.S. Jewett, Antonio Finelli, Claude Schulman, Yair Lotan, Shahrokh F. Shariat, Joelle Nortier  European Urology  Volume 59, Issue 6, Pages 1026-1031 (June 2011) DOI: 10.1016/j.eururo.2011.03.027 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 Patient clinical stage diagnosis and outcome distribution. AAN=aristolochic acid nephropathy; BC=bladder cancer; CIS=cancer in situ. European Urology 2011 59, 1026-1031DOI: (10.1016/j.eururo.2011.03.027) Copyright © 2011 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.